"Today the United States leads the world in biopharmaceutical innovation, with American companies driving 55% of global R&D and producing more new medicines than any other country. That leadership translates directly to patients, with roughly 70% of new medicines launching first in the U.S., giving Americans access to breakthrough treatments months, often years, ahead of other countries."
"We are entering an era where breakthroughs move faster from lab to patient. Diseases are detected earlier. Treatments are tailored more precisely. High-quality care is reaching more people. Progress is no longer defined only by what we discover, but by how early and effectively we put those discoveries to work."
"In cardiovascular care, American innovation is giving critically ill patients meaningful additional time - time to recover, to return home, to lead fuller lives. In cancer, innovation has fundamentally changed the outlook. Diseases once considered fatal are increasingly manageable, and in some cases potentially curable, as science turns the body's own biology into a powerful tool against disease."
"Artificial intelligence is accelerating this progress, and the U.S. leads here, too. It is transforming how our scientists discover medicines, design clinical trials, and match therapies to the patients most likely to benefit. Research timelines that once spanned decades"
American innovation has transformed healthcare by turning once-unimaginable ideas into lifesaving realities. The United States continues to lead in biopharmaceutical innovation, with American companies driving a large share of global R&D and producing more new medicines than any other country. New medicines often launch first in the U.S., giving patients earlier access to breakthrough treatments. Breakthroughs are moving faster from lab to patient, with earlier disease detection, more precise treatment tailoring, and broader access to high-quality care. Cardiovascular innovation provides additional time for recovery and returning home. Cancer innovation increasingly makes diseases manageable and sometimes curable by using the body’s biology. Artificial intelligence accelerates medicine discovery, clinical trial design, and therapy matching to likely responders.
#biopharmaceutical-innovation #healthcare-technology #artificial-intelligence #cardiovascular-care #cancer-research
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]